Although the revenue and EPS for R1 RCM INC (RCM) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
R1 RCM Inc. (RCM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to break-even earnings per share a year ago.
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own R1 Rcm Inc ("RCM" or the "Company") (NASDAQ:RCM) stock purchased prior to February 23, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of whether the board of directors of RCM breached its fiduciary duties owed to the company's stockholders.
| Insurance Industry | Financials Sector | Lee Rivas CEO | NASDAQ (NGS) Exchange | 77634L105 CUSIP |
| US Country | 29,400 Employees | - Last Dividend | 22 Jun 2022 Last Split | 20 May 2010 IPO Date |
R1 RCM Inc. specializes in providing comprehensive technology-driven solutions designed to enhance the financial performance and patient experience within health systems, hospitals, and physician groups. With a focus on creating an operating partnership through end-to-end solutions, R1 RCM Inc. aims at improving the financial leverage and revenue of its healthcare clientele. Established in 2003 and based in Murray, Utah, the company stands out for its wide-ranging modular solutions tailored to meeting the specific revenue cycle management needs of its customers, ensuring a significant impact on their financial health and regulatory compliance.